Antibodies to IL-6 and use thereof
    2.
    发明授权
    Antibodies to IL-6 and use thereof 有权
    IL-6抗体及其用途

    公开(公告)号:US07935340B2

    公开(公告)日:2011-05-03

    申请号:US12153612

    申请日:2008-05-21

    摘要: The present invention is directed to antibodies and fragments thereof having binding specificity for IL-6. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the VH, VL and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-IL-6 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-IL-6 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-IL-6 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with IL-6. These antibodies may bind at least one of soluble IL-6, cell surface expressed IL-6, IL-6/IL-6R and/or prevent the association of IL-6 and IL-6R, the association of IL-6/IL-6R and gp130 and or the formation of IL-6/IL-6R/gp130 multimers and thereby inhibit a biological effect associated with any of the foregoing.

    摘要翻译: 本发明涉及对IL-6具有结合特异性的抗体及其片段。 本发明的另一个实施方案涉及本文所述的抗体及其结合片段,其包含本文所述的VH,VL和CDR多肽的序列,以及编码它们的多核苷酸。 本发明还涉及抗IL-6抗体及其与一个或多个功能或可检测部分缀合的结合片段的缀合物。 本发明还考虑制备所述抗IL-6抗体及其结合片段的方法。 本发明的实施方案还涉及抗IL-6抗体及其结合片段用于诊断,评估和治疗与IL-6相关的疾病和病症的用途。 这些抗体可以结合可溶性IL-6,细胞表面表达的IL-6,IL-6 / IL-6R中的至少一种和/或阻止IL-6和IL-6R的结合,IL-6 / IL -6R和gp130,或者形成IL-6 / IL-6R / gp130多聚体,从而抑制与前述任何相关的生物学作用。

    Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
    4.
    发明授权
    Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies 有权
    编码IL-6抗体的核酸和抗IL-6抗体的重组产生

    公开(公告)号:US08062864B2

    公开(公告)日:2011-11-22

    申请号:US12366567

    申请日:2009-02-05

    摘要: The present invention is directed to antibodies and fragments thereof and humanized versions thereof having binding specificity for IL-6. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the VH, VL and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-IL-6 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-IL-6 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-IL-6 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with IL-6. These antibodies may bind at least one of soluble IL-6, cell surface expressed IL-6, IL-6/IL-6R and/or prevent the association of IL-6 and IL-6R, the association of IL-6/IL-6R and gp130 and or the formation of IL-6/IL-6R/gp130 multimers and thereby inhibit a biological effect associated with any of the foregoing.

    摘要翻译: 本发明涉及对IL-6具有结合特异性的抗体及其片段和人源化形式。 本发明的另一个实施方案涉及本文所述的抗体及其结合片段,其包含本文所述的VH,VL和CDR多肽的序列,以及编码它们的多核苷酸。 本发明还涉及抗IL-6抗体及其与一个或多个功能或可检测部分缀合的结合片段的缀合物。 本发明还考虑制备所述抗IL-6抗体及其结合片段的方法。 本发明的实施方案还涉及抗IL-6抗体及其结合片段用于诊断,评估和治疗与IL-6相关的疾病和病症的用途。 这些抗体可以结合可溶性IL-6,细胞表面表达的IL-6,IL-6 / IL-6R中的至少一种和/或阻止IL-6和IL-6R的结合,IL-6 / IL -6R和gp130,或者形成IL-6 / IL-6R / gp130多聚体,从而抑制与前述任何相关的生物学作用。

    Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
    7.
    发明授权
    Use of anti-IL-6 antibodies having specific binding properties to treat cachexia 有权
    使用具有特异性结合特性的抗IL-6抗体治疗恶病质

    公开(公告)号:US08178101B2

    公开(公告)日:2012-05-15

    申请号:US12391717

    申请日:2009-02-24

    摘要: The present invention is directed to antibodies and fragments thereof and humanized versions thereof having binding specificity for IL-6. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the VH, VL and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-IL-6 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-IL-6 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-IL-6 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with IL-6. These antibodies may bind at least one of soluble IL-6, cell surface expressed IL-6, IL-6/IL-6R and/or prevent the association of IL-6 and IL-6R, the association of IL-6/IL-6R and gp130 and or the formation of IL-6/IL-6R/gp130 multimers and thereby inhibit a biological effect associated with any of the foregoing.

    摘要翻译: 本发明涉及对IL-6具有结合特异性的抗体及其片段和人源化形式。 本发明的另一个实施方案涉及本文所述的抗体及其结合片段,其包含本文所述的VH,VL和CDR多肽的序列,以及编码它们的多核苷酸。 本发明还涉及抗IL-6抗体及其与一个或多个功能或可检测部分缀合的结合片段的缀合物。 本发明还考虑制备所述抗IL-6抗体及其结合片段的方法。 本发明的实施方案还涉及抗IL-6抗体及其结合片段用于诊断,评估和治疗与IL-6相关的疾病和病症的用途。 这些抗体可以结合可溶性IL-6,细胞表面表达的IL-6,IL-6 / IL-6R中的至少一种和/或阻止IL-6和IL-6R的结合,IL-6 / IL -6R和gp130,或者形成IL-6 / IL-6R / gp130多聚体,从而抑制与前述任何相关的生物学作用。